Abstract
The conserved transcription factor Myc regulates cell growth, proliferation and apoptosis, and its deregulation has been associated with human pathologies. Although specific miRNAs have been identified as fundamental components of the Myc tumorigenic program, how Myc regulates miRNA biogenesis remains controversial. Here we showed that Myc functions as an important regulator of miRNA biogenesis in Drosophila by influencing both miRNA gene expression and processing. Through the analysis of ChIP-Seq datasets, we discovered that nearly 56% of Drosophila miRNA genes show dMyc binding, exhibiting either the canonical or non-canonical E-box sequences within the peak region. Consistently, reduction of dMyc levels resulted in widespread downregulation of miRNAs gene expression. dMyc also modulates miRNA processing and activity by controlling Drosha and AGO1 levels through direct transcriptional regulation. By using in vivo miRNA activity sensors we demonstrated that dMyc promotes miRNA-mediated silencing in different tissues, including the wing primordium and the fat body. We also showed that dMyc-dependent expression of miR-305 in the fat body modulates Dmp53 levels depending on nutrient availability, having a profound impact on the ability of the organism to respond to nutrient stress. Indeed, dMyc depletion in the fat body resulted in extended survival to nutrient deprivation which was reverted by expression of either miR-305 or a dominant negative version of Dmp53. Our study reveals a previously unrecognized function of dMyc as an important regulator of miRNA biogenesis and suggests that Myc-dependent expression of specific miRNAs may have important tissue-specific functions.
Author summary
Myc is a conserved transcription factor that regulates the expression of a large number of genes, and has long been recognized as a major driver of human tumorigenesis. In addition to well-described Myc target genes such as those involved in ribosome biogenesis, Myc is also able to regulate the expression of microRNAs (miRNAs). Both Myc and miRNAs have been shown to influence cell proliferation, and their deregulation has been associated with different human pathologies. Indeed, specific miRNAs have been identified as fundamental components of the Myc tumorigenic program. In this work, we find that Drosophila Myc (dMyc) regulates the expression of a large number of miRNAs through direct transcriptional regulation. We also find that Myc-dependent expression of specific miRNAs may have important tissue-specific functions. Through the regulation of miR305 in the adipose tissue, dMyc maintain low p53 levels under normal conditions. In contrast, under nutrient stress, reduced dMyc levels alleviates miR305-mediated repression of p53. Once activated, p53 promotes metabolic homeostasis and organismal survival to nutrient stress. Given the role of dMyc and miRNAs in human pathologies, our findings will be important in understanding the complex regulatory mechanisms of physiological and pathological responses in humans.
Introduction
Myc is a conserved basic helix–loop–helix leucine zipper (bHLHZ) transcription factor that regulates the expression of an estimated 10–15% of human genes [1]. This transcription factor has long been recognized as a key regulator of cell growth, proliferation and metabolism and its deregulation has been associated with human cancer [2,3]. Myc forms a heterodimeric DNA binding complex with the small bHLHZ protein Max and binds to the canonical enhancer-box (E-box) sequence CACGTG to modulate transcription of nearby genes [1,3,4]. The number of Myc-regulated genes is large, and encompasses a broad range of biological functions including virtually every anabolic and growth-promoting process [3].
Emerging evidence has demonstrated that Myc is also able to regulate the expression of non-coding RNAs [2,5–8]. MicroRNAs (miRNAs) are short non-coding RNAs that regulate the expression of target genes by directly binding to their mRNAs [9]. Hundreds of miRNAs have been listed in higher animals, and deregulation of many of them has been associated with cancer [10]. The biogenesis of miRNA is tightly regulated at both transcriptional and post-transcriptional levels. Primary miRNAs (pri-miRNAs) are transcribed by RNA Pol II and folded into a hairpin-like structure, facilitated by the presence of complementary sequences. The hairpin structure of the pri-miRNA is recognized and processed by an enzyme called Drosha, resulting in the production of a shorter RNA molecule called a precursor miRNA (pre-miRNA). The pre-miRNA is then exported from the nucleus to the cytoplasm, where it undergoes further processing by Dicer-1 (Dcr-1), leading to the production of ∼22-nt miRNA duplexes. Once loaded into the Argonaute-1 (AGO-1) containing miRNA-Induced Silencing Complex (miRiSC), the mature single-stranded miRNA guides the miRISC to the 3′ untranslated region (UTR) of target mRNAs [11–13].
Transcription of miRNAs is regulated by RNA Pol II-associated transcription factors (TFs) and epigenetic regulators [9]. Among these TFs, Myc has been shown to either activate or repress transcription of specific miRNA genes. On one hand, Myc has been shown to activate expression of the miR-17–92 cluster, a pro-tumorigenic group of six miRNAs, in human cells [7,8]. Expression of the miR-17–92 cluster is frequently observed in tumors, promotes proliferation in cell lines, and accelerates tumorigenesis in mouse models of Myc-induced colon cancer and lymphoma [7,8]. On the other hand, a large set of additional miRNAs have been shown to be repressed by Myc in human and mouse models of B cell lymphoma [6]. Interestingly, expression of Myc-repressed miRNAs markedly impairs lymphoma cell growth in vivo [6]. Myc has also been shown to modulate miRNA processing via the transcriptional regulation of Drosha in P493-6 human B cell line [14]. Although not entirely understood, these observations point towards Myc as an important regulator of miRNA biogenesis and suggest that Myc-dependent activation and/or repression of specific miRNAs is a fundamental component of the Myc tumorigenic program.
Similarly to its human counterpart, the single Drosophila Myc protein (dMyc) also plays an essential role in controlling cell growth and proliferation through the transcriptional regulation of a large number of target genes [15–21]. Although dMyc has been shown to regulate the expression of specific miRNAs [22,23], the exact role of dMyc in regulating miRNA expression and/or processing is largely unknown. In this study, we identified a large set of Myc-regulated miRNAs in Drosophila. We showed that dMyc regulates miRNA transcription by directly binding to either the canonical or non-canonical E-box sequences located in at least 56% of the Drosophila miRNAs. In addition, direct transcriptional regulation of Drosha and AGO1 by dMyc also allows for modulation of miRNA processing and activity. Through in vivo miRNA activity sensors, we demonstrate that dMyc promotes miRNA-mediated silencing in different Drosophila tissues such as the wing primordium and the fat body, a functional analog of vertebrate liver and adipose tissue. Interestingly, dMyc-dependent expression of miR-305 in the fat body is critical to modulate Dmp53 levels (the Drosophila ortholog of mammalian p53), this being crucial for metabolic homeostasis maintenance and animal survival upon nutrient stress. Our study reveals a previously unrecognized function of dMyc as a major regulator of miRNA expression and processing.
Results
Myc regulation of miRNAs gene expression in Drosophila
To explore a possible role of dMyc in regulating miRNA gene expression we made use of the gene-switch GAL4 system (GSG) that allows for conditional expression of a mycRNAi transgene [24]. An inactive GAL4-progesterone-receptor fusion protein is expressed under the control of an ubiquitous promoter and becomes active only in the presence of the activator RU-486 [24]. As shown in Fig 1A, GSG162>mycRNAi animals exposed to RU-486 for 72 h showed reduced dmyc transcript levels when compared to vehicle-treated controls. We then measured the levels of primary miRNA (pri-miRNA) for a randomly selected group of miRNA genes by qRT-PCR and observed that expression of almost every tested pri-miRNAs was downregulated in GSG162>mycRNAi animals (Fig 1B). Interestingly, GSG162>mycRNAi animals also presented reduced levels of precursor miRNAs (pre-miRNA) and mature miR-219 and miR-305 (Fig 1C and 1D). No differences were observed in the levels of miR-8 and miR-283 (Fig 1C), most probably indicating differences in the stability and/or turnover of mature miRNAs. We then evaluated the effect of overexpressing dMyc on pri-miRNA expression by using a transgenic line expressing dMyc under the control of a tubulin promoter (tub>dMyc; [18]) which resulted in a two to three-fold increase in dmyc transcript levels (S1A Fig). In this case, we observed the upregulation of pri-miR-283, pri-miR-306, pri-miR-6, and pri-miR-2a, while no significant differences were detected for other pri-miRNAs (S1B Fig). The absence of significant effects on miRNA transcription upon dMyc overexpression may be attributed to the saturation of dMyc occupancy on the promoter regions of miRNA genes. Collectively, these findings provide compelling evidence for the regulatory role of dMyc in controlling the expression of a substantial number of miRNAs in Drosophila.
Fig 1. Myc-mediated regulation of miRNA gene expression in Drosophila.
(A) qRT-PCR showing myc transcript levels in GSG162>mycRNAi larvae in the presence of RU486 or vehicle. (B-D) qRT-PCR showing relative RNA levels of the indicated primary (B), precursor (D) or mature (C) miRNAs in GSG162>mycRNAi larvae in the absence or presence of RU486. Results are expressed as fold induction with respect to control animals. Three independent replicates were carried out for each sample. Mean ± SEM. Unpaired two-tailed t-tests: * p<0.05; ** p<0.01; ***p<0.001; ns: not significant. See also S1 Fig.
dMyc association to miRNA genomic region
A curated database of dMyc-binding sites obtained from whole-genome Chromatin IP sequencing (ChIP-Seq) assays using whole L3 Drosophila larvae have been made available by the modENCODE Consortium [25]. We therefore used modENCODE datasets to evaluate whether miRNA genes are direct targets of dMyc (http://epic.gs.washington.edu/modERN). We focused the analysis on the 253 miRNA genes listed in the Drosophila miRNA database (miRBase Release 22.1, http://www.mirbase.org), and found 111 dMyc regulatory regions potentially covering 119 miRNAs (Fig 2A and S1 Table, see Materials and methods for details). Similar results were obtained when using dMyc ChIP-Seq datasets from Drosophila cultured cells available in the TransmiR v2.0 database [26] (Fig 2A). Interestingly, a total of 142 miRNAs were identified in at least one of these datasets, representing 56% of annotated miRNA transcripts in the Drosophila genome. Further characterization of the dMyc-associated miRNAs genomic regions showed a high presence of either canonical or non-canonical E-box sequences previously described for human Myc proteins, suggesting a direct role of dMyc in the regulation of miRNAs expression (Figs 2B, 2C and S2 and S1 Table, see Materials and methods for details). An enrichment analysis based on the hypergeometric distribution revealed a significant over-enrichment of miRNA genes, with a fold enrichment of 2.64 compared to random expectations (hypergeometric p-value = 7.7e-25). This finding strongly supports the highly significant association between dMyc and miRNA genes.
Fig 2. Identification of Myc-regulated miRNAs in Drosophila.
(A) Venn diagrams showing overlap between ChIP-seq databases for dMyc [25,26]. (B-C) Canonical and non-canonical E-box sequences overlapping dMyc peaks in the locus of candidate dMyc-regulated miRNA genes. (D) ChIP-qPCR assays showing dMyc binding to the locus of indicated genes. Results are expressed as fold enrichment with respect to control anti-GFP samples. Mean ± SEM. Unpaired two-tailed t-tests: * p<0.05; ** p<0.01; ***p<0.001; ns: not significant. See also S1 Table and S2 Fig.
We confirmed dMyc binding to the genomic locus of a selected group of miRNA genes by performing ChIP-qPCR experiments using a previously validated anti-dMyc antibody [27]. We observed significant enrichment of the selected miRNA genes and the positive control RpS15a [27] in dMyc-ChIP samples when compared with the negative control (Fig 2D). Altogether, these findings demonstrate in vivo association of dMyc with immediate regions next to 115 miRNA genes that contain either the canonical or the non-canonical E-box sequences, providing strong evidence that these miRNAs are directly regulated by dMyc.
dMyc regulation of main miRNA biogenesis factors
Emerging data have provided evidence that Myc is able to regulate the expression of Drosha, an enzyme involved in the nuclear processing of pri-miRNAs [14]. Interestingly, the transcript levels of dcr-1, drosha and ago1 were strongly reduced in larvae expressing mycRNAi (Fig 3A), whereas they were upregulated in tub>dMyc animals (Fig 3B). We then evaluated dMyc binding to the genomic locus of these genes by ChIP-qPCR and observed a significant association of dMyc to the promoter region of ago1 and drosha (Fig 3C). However, dMyc was not found to be enriched in dcr-1 promoter, meaning the effect of dMyc depletion on Dcr-1 levels might be indirect. Taken together, these results suggest that dMyc activity is required for miRNA biogenesis to regulate the expression of both pri-miRNAs and central elements of the miRNA machinery.
Fig 3. Myc regulation of the miRNA machinery.
(A-B) qRT-PCR showing dcr1, drosha and ago1 mRNA levels in GSG162>mycRNAi larvae treated with RU486 or vehicle (A), as well as in tub>dMyc larvae (B). Results are expressed as fold induction relative to control animals. Three independent replicates were carried out for each sample. (C) ChIP-qPCR assays showing dMyc binding to the promoter region of the indicated genes. Results are expressed as fold enrichment with respect to control anti-GFP samples. Mean ± SEM. Unpaired two-tailed t-tests: * p<0.05; ** p<0.01; ***p<0.001; ns: not significant.
Myc regulates miRNA activity sensor in the Drosophila wing primordium
The expression of the Drosophila ortholog of mammalian p53 (Dmp53) has previously been shown to be regulated by miRNAs in both the wing imaginal disc and the fat body [28]. Notably, three specific miRNAs (miR-283, miR-219, miR-305), previously identified as regulators of Dmp53 expression in the wing primordium [28], showed reduced levels upon mycRNAi expression (Fig 1B) and exhibited dMyc binding to its genomic region (Fig 2D and S1 Table). We then made use of a miRNA sensor that exploits the regulation of p53 expression by miRNAs in the larval wing primordium to characterize dMyc contribution in miRNA biogenesis. To assess for miRNA-mediated regulation of Dmp53 we used a p53-3’UTR sensor consisting of the wild type Dmp53 3’UTR cloned into a tubulin-promoter-EGFP reporter plasmid, showing increased GFP expression levels when interfering with the miRNA machinery (S3 Fig; [28]). Consistent with a role of dMyc in regulating miRNA biogenesis, expression of mycRNAi in a stripe of anterior cells adjacent to the AP boundary, using ptc-Gal4, led to increased GFP levels of the p53-sensor (Fig 4A and 4B, see also Fig 4D for quantifications of GFP intensity levels). Conversely, dMyc overexpression using the dpp-Gal4 driver resulted in a significant reduction in the GFP signal (Fig 4C and 4D). It is noteworthy that a previous report indicated that dMyc overexpression in the wing primordium leads to an increase in the activity levels of bantam [29]. We then extended our analysis to include alternative miR-GFP sensors based on Mei-p26 or dMyc 3’UTRs, known to be regulated by miRNAs in the Drosophila wing imaginal disc [30,31]. Intriguingly, dMyc-depletion increased the expression of these miR-GFP sensors (Fig 4D, 4E and 4G) and dMyc overexpression resulted in a strong reduction of GFP levels (Fig 4D, 4F and 4H) compared with control discs showing ubiquitous GFP expression (S3 Fig). These findings indicate that the regulatory influence of dMyc extends beyond miRNAs targeting Dmp53. Moreover, our results indicate that dMyc plays a crucial role in regulating miRNA biogenesis in the Drosophila wing primordium, influencing either miRNA gene expression or processing.
Fig 4. Myc regulation of miRNA activity sensor in the wing primordium.
(A-C) Wing discs carrying the p53-sensor along with the indicated transgenes and stained to visualize GFP (in green or white). (D) Relative GFP intensity levels between Anterior (patched) and Posterior domains of wing discs from the indicated genotypes. (E-H) Wing discs carrying the meip26-sensor (E-F) or myc-sensor (G-H) along with the indicated transgenes and stained to visualize GFP (in green or white). The wing discs in (B,E,G) expressed mycRNAi under the control of the ptc-Gal4 driver (marked by the expression of RFP, in red). The wing discs in (C,F,H) expressed dMyc under the control of the dpp-Gal4 driver (marked by the expression of RFP, in red). Note increased GFP levels in dMyc-depleted cells, but reduced expression in dMyc-overexpressing cells. Red arrowheads depict the anterior-posterior (A-P) boundary. A: anterior; P: posterior. See also S3 Fig.
dMyc regulates miR-305 expression in the fat body according to nutrient availability
Expression of core elements of the miRNA machinery have been previously shown to be regulated by nutrient availability in the FB of starved animals [28]. Upon starvation, reduced Dcr-1 levels and impaired miRNA biogenesis results in Dmp53 activation which, in turn, promotes metabolic homeostasis and organismal survival to nutrient stress [28,32]. Accordingly, mRNA levels of dcr-1 and drosha were significantly reduced after 24h starvation treatment in both adult abdomens [28] and larval FB (Fig 5A). dMyc transcript levels were also reduced in the FB of starved animals (Fig 5A) and expression levels of dcr-1 and drosha were strongly reduced in larvae expressing mycRNAi (Fig 3A), thus raising the possibility that decreased expression of miRNA biogenesis genes in the FB might be a direct consequence of reduced dMyc levels. However, even though tub>dMyc animals showed sustained dMyc levels after 24h starvation, ubiquitous expression of dMyc was not able to rescue the reduced levels of dcr-1 and drosha observed in the FB of starved animals (Fig 5C). Similar results were obtained by overexpressing dMyc with the GSG162-Gal4 driver in the presence of RU486 (S4 Fig). Among the three miRNAs previously shown to regulate Dmp53 expression in the wing primordium only miR-305 has been shown to repress Dmp53 expression in the FB [28]. Interestingly, expression of pri-miR-305 was significantly reduced in the FB of dMyc-depleted animals (Fig 5B) and showed dMyc binding to its promoter region (Fig 2A and 2D), raising the possibility that miR-305 expression itself might be compromised under nutrient deprivation. Indeed, pri-miR-305 levels were reduced in the FB of starved larvae and dMyc overexpression was sufficient to revert pri-miR-305 expression to normal levels (Fig 5D). Together, these findings suggest that the transcription of miR-305 is directly regulated by dMyc, while the expression of Dcr-1 and Drosha in the fat body under nutrient deprivation involves a dMyc-independent mechanism. Interestingly, a recent study has reported that the transcription factor FOXO represses Dcr-1 expression levels under nutrient deprivation, indicating the involvement of alternative regulatory pathways [33]. Further investigation is required to determine whether Drosha is also negatively regulated under nutrient stress.
Fig 5. dMyc-dependent regulation of pri-miR-305 in the fat body.
(A) qRT-PCR showing myc, dcr1 and drosha mRNA levels in the FB of larvae subjected to fed or starved conditions. (B) qRT-PCR showing pri-miR-305 levels in the FB of GSG162>mycRNAi larvae in the absence or presence of RU486. (C-D) qRT-PCR showing myc, dcr1 and drosha transcript levels (C) or pri-miR-305 levels (D) in the FB of larvae from the indicated genotypes subjected to fed (WF) or starved (STV) conditions. Results are expressed as fold induction with respect to control animals. (E-F) The flipout-Gal4 line was used to overexpress dMyc in single fat body cells, allowing us to investigate the influence of dMyc expression on p53-sensor levels. Notably, expression of dMyc in single fat body cells (marked by RFP, in red or white) led to a decrease in p53-sensor levels of both fed and starved animals (E; in green or white), while having no effect on the expression of the p53Δ305-sensor (F; in green or white). Mean ± SEM. Unpaired two-tailed t-tests: * p<0.05; ** p<0.01; ***p<0.001; ns: not significant. Scale bars, 20 μm. See also S4 Fig.
dMyc-dependent regulation of miR-305 expression contributes to starvation resistance
We then decided to study the functional consequences of dMyc-dependent expression of miR-305 on Dmp53 levels and organismal survival upon nutrient stress. To monitor Dmp53 repression by miR-305, we used either p53-3’UTR sensor or p53Δ305–3’UTR sensor lacking the predicted miR-305 binding site [28]. When exposed to nutrient deprivation, the p53-sensor showed increased GFP levels while the p53Δ305-sensor showed no changes in this parameter [28]. Consistent with a role of dMyc in controlling miR-305-mediated repression of Dmp53, dMyc overexpressing cells showed reduced p53-sensor levels in fat body cells of both well fed and starved animals, but had no effect on the expression of the p53Δ305-sensor (Figs 5E, 5F and S4; Myc expressing cells were marked by the expression of red fluorescent protein).
Next, we evaluated whether dMyc-mediated expression of miR-305 in the FB has an impact on the survival rates of adult flies subjected to nutrient deprivation and whether this effect relied on the activity of Dmp53. Targeted expression of mycRNAi in FB cells (Lsp2>mycRNAi flies) increased the survival rates of both male and female adult flies subjected to nutrient starvation when compared to control flies (Fig 6A and 6B and S2 Table). Interestingly, the extended survival rates were reverted upon coexpression of either a miR-305 hairpin [34] (Lsp2>mycRNAi, miR-305 flies; Fig 6A and 6B and S2 Table) or the dominant-negative form Dmp53H159.N (Lsp2>mycRNAi, p53H159.N flies; Figs 6E, S5C and S2 Table). Similar results were obtained when modulating dMyc or miR-305 levels specifically in the adult FB using the GSG132-Gal4 driver in the presence of RU486 (S5A Fig and S2 Table). Conversely, whereas ubiquitous dMyc expression (tub>dMyc flies) compromised the survival rates of adult flies exposed to starvation conditions (Fig 6C and 6D and S2 Table), reducing miR-305 activity by expression of a miR-305 sponge construct [35] in the FB completely reverted the starvation sensitivity caused by dMyc overexpression (tubMyc; Lsp2>miR-305sponge flies; Fig 6C and 6D and S2 Table). Finally, in accordance with a model where Dmp53 activation enhances survival, the conditional expression of Dmp53 in the FB of adult flies increased survival rates during nutrient deprivation (S5B Fig). Altogether, these findings indicate that dMyc regulates miR-305 expression in the FB in a nutrient dependent manner, therefore influencing Dmp53 levels and the resistance to nutrient stress.
Fig 6. Starvation Resistance upon FB-Specific modulation of dMyc, miR-305 and Dmp53.
(A-F) Survival rates to nutrient deprivation of adult flies of the indicated genotypes compared to control flies subjected to the same procedure. Both male (A, C, E) and female (B, D) adult flies were analyzed. See S2 Table for n, p-value, median, and maximum survival values. Error bars represent SEM. (G) dMyc stimulates the transcription of pri-miR305, leading to the repression of Dmp53 expression in the FB of fed animals. Under nutrient deprivation, dMyc levels decrease, and FOXO is activated, impairing miR-305 expression and processing. As a consequence, Dmp53 is activated, which facilitates energy homeostasis and supports animal survival during nutrient stress. See also S5 Fig.
Discussion
Although c-Myc-dependent regulation of specific miRNAs has been positioned as a fundamental component of the c-Myc tumorigenic program, how c-Myc modulates miRNA biogenesis remains controversial. In this study, we provide evidence that dMyc functions in Drosophila as an important regulator of miRNA biogenesis, influencing both miRNA gene expression and processing. By combining bioinformatic and experimental data we demonstrate that dMyc associates to the locus of a large set of miRNA genes, and reduction of dMyc levels results in widespread downregulation of miRNA expression. Eleven such miRNAs have previously been identified as putative dMyc-regulated miRNAs based on in silico promoter analysis [22], and two of them (miR-277 and miR-308) have been validated as dMyc-targets [22,23]. We also conclude that dMyc can affect miRNA processing and activity by controlling drosha and ago1 levels through direct transcriptional regulation. Previous studies in mice and human cell lines have indicated that c-Myc is able to either activate or repress transcription of specific miRNA genes, as well as to modulate the processing of miRNAs via transcriptional regulation of drosha, thus suggesting a conserved mechanism [6–8,14]. Even though our results suggest that dMyc positively regulates miRNA gene expression, we cannot rule out the possibility of an opposite effect of dMyc on miRNA transcription depending on cell type and physiological context.
By using in vivo miRNA activity sensors we demonstrate that dMyc promotes miRNA-mediated silencing in different tissues, including the wing primordium and fat body. Interestingly, dMyc-dependent expression of miR-305 in the fat body modulates Dmp53 levels according to nutrient availability, which has a profound impact on the ability of the organism to respond to nutrient stress. dMyc depletion in the fat body resulted in extended survival to nutrient deprivation, which was reverted by coexpression of either miR-305 or a dominant negative version of Dmp53. Myc has also been shown to modulate the Drosophila immune response via direct activation of miR-277 transcription [22], strongly suggesting that Myc-dependent expression of specific miRNAs may have important tissue-specific functions. Along with its role in the regulation of Dmp53 levels in the adipose tissue, miR-305 has been shown to mediate adaptive homeostasis in the gut [36] and to participate in the aging process [37]. Interestingly, miR-305 expression in intestinal stem cells is under nutritional control [36]. As an age-related miRNA, ubiquitous expression of miR-305 promotes the accumulation of protein aggregates in the muscle, leading to age-dependent impairment in locomotor activity, and reduced lifespan [37]. Conversely, miR-305 depletion in Drosophila adults suppresses these phenotypes and extended lifespan [37]. Together, these findings provide clear evidence that miR-305 is required in different tissues for adaptive homeostasis in response to changing environmental conditions. To what extent dMyc-dependent regulation of miR-305 expression has an impact on gut homeostasis and longevity remains to be studied.
Dcr-1 has been shown to play a critical role in regulating metabolism and stress resistance in flies [28], as well as to promote cell cycle progression during Drosophila wing development [30]. Importantly, Dcr-1 has been identified in the adipose tissue of both mice and Drosophila as a rate-limiting enzyme in the biogenesis of miRNAs [28,38]. Under nutrient deprivation, the processing of miRNAs is impaired as a consequence of reduced Dcr-1 expression [28]. We examined Dcr-1 levels in response to dMyc expression and found reduced dcr-1 mRNA levels in dMyc-depleted animals. However, our ChIP assay showed no association of dMyc to the Dcr-1 locus suggesting that the effect of dMyc depletion on Dcr-1 levels might be indirect. Most importantly, whereas dMyc overexpression reverted the reduced expression of pri-miR-305 under starvation, it was not able to rescue the reduced levels of dcr-1 observed in the FB of starved animals. These results indicate that whereas miR-305 transcription requires direct action of dMyc, a dMyc-independent mechanism is involved in the regulation of Dcr-1 expression under nutrient deprivation. Accordingly, the transcription factor FOXO has recently been shown to repress Dcr-1 expression in the Drosophila fat body through direct transcriptional regulation [33]. JNK-dependent activation of FOXO in the fat body of starved animals represses Dcr-1 expression which, in turn, leads to reduced miRNA biogenesis. In this scenario, dMyc promotes the transcription of pri-miR305, resulting in the repression of Dmp53 expression in the fat body of well-fed animals (Fig 6F). Under nutrient deprivation, dMyc levels decrease, and FOXO becomes activated, impairing miR-305 expression and processing. This, in turn, leads to the activation of Dmp53, promoting energy homeostasis and enhancing animal survival under nutrient stress (Fig 6F). Altogether, these findings illustrate how different transcription factors converge on regulating miRNA biogenesis in a tissue-specific and context-dependent manner.
Materials and methods
Drosophila strains and maintenance
The following Drosophila strains were used: GSG162 (BL40260), GSG132 (BL8527), Lsp2-Gal4 (BL6357), Cg-Gal4 (BDSC:7011); UAS-mycRNAi (VDRC2947); UAS-dMyc (BL9674); tub-dMyc [18]; UAS-Dmp53H159N (BL8420); UAS-Dmp53 (BL6584); UAS-miR-305 (BL41152); UAS-miR-305sponge (BL61423); p533’UTR-sensor [28]; p53Δ3053’UTR-sensor [28]; Myc3’UTR-sensor [31]; meiP263’UTR-sensor [30]. Other stocks are described in Flybase. Flies were reared at 25°C on standard media containing: 4% glucose, 40 g/L powder yeast, 1% agar, 25 g/L wheat flour, 25 g/L cornflour, 4 ml/L propionic acid and 1.1 g/L nipagin. For experiments using the Gene Switch system, embryos containing the GS-Gal4 driver and the UAS-mycRNAi transgene were collected over 24 h and maintained in regular food. In order to induce transgene expression, second instar larvae were transferred to food containing 50 μg/ml of RU486 (Sigma) or an equivalent volume of MilliQ water as a control. After 72h, full larvae or dissected tissues were used for RNA extraction.
Fly husbandry and mosaic analysis
The Gal4/UAS binary system was used to drive transgene expression in the different Drosophila tissues [39] and experimental crosses were performed at 25°C, unless otherwise specified. Crossing all Gal4 driver lines to the w1118 background provided controls for each experiment. The Flp/Out system was used to generate RFP-marked clones. Flies from hsFLP; act>y+>Gal4, UAS-RFP were crossed to corresponding UAS-transgene lines at 25°C and spontaneous recombination events taking place in the fat body prior to the onset of endoreplication were analyzed [40].
Starvation treatments and survival experiments
For starvation treatments in larvae, eggs were collected for 4 h intervals and larvae were transferred to vials containing standard food immediately after eclosion (first instar larvae, L1) at a density of 50 larvae per tube. Larvae were then raised at 25°C for 72h prior to the starvation assay. Mid-third instar larvae were washed with PBS and placed in inverted 60 mm petri dishes with phosphate-buffered saline (PBS) soaked Whatman paper (starvation, STV) or maintained in standard food (well fed, WF). Each plate was sealed with parafilm and incubated at 25°C for the duration of the experiment. After the starvation period, full larvae or dissected fat bodies were used for immunostaining or RNA extraction. For starvation sensitivity assays, 5- to 7-day-old flies of each genotype were transferred into vials containing 2% agar in PBS. Flies were transferred to new tubes every day, and dead flies were counted every six hours. Control animals were always analyzed in parallel in each experimental condition. Number of individuals used in each experiment is detailed in S2 Table. For starvation sensitivity assays using the GSG132-Gal4 line (S5 Fig), newly eclosed adults were transferred to food supplemented with 50 μg/ml of RU486 (Sigma). After 5- to 7-days, flies of each genotype were transferred into vials containing 2% agar in PBS along with 50 μg/ml of RU486.
Immunostainings
Mid-third instar larvae were dissected in cold PBS and fixed in 4% formaldehyde/PBS for 20 min at room temperature. They were then washed and permeabilized in PBT (0.2% Triton X-100 in PBS) for 30 min and blocked in BBT (0.3% BSA, 250 mM NaCl in PBT) for 1 h. Samples were incubated overnight at 4°C with primary antibody diluted in BBT, washed three times (15 min each) in BBT and incubated with secondary antibodies for 1.5 hours at room temperature. After three washes with PBT (15 min each), dissected tissues were placed in a mounting medium (80% glycerol/PBS containing 0.05% n-Propyl-Gallate). The following primary antibodies were used: mouse anti-GFP (12A6, DSHB); mouse anti-dMyc (P4C4-B10, DSHB); mouse anti-Dmp53 (7A4, DSHB). The following secondary antibodies were used: anti-mouse IgG-Alexa Fluor 488; anti-mouse IgG-Alexa Fluor 594 (Jackson InmunoResearch).
For fluorescence quantification, confocal images were taken using a Leica SP8 confocal microscope maintaining identical microscope settings for both control and experimental samples. Using Fiji software, fluorescence intensity were measured within defined areas of the Anterior (patched) and Posterior domains and represented as an A/P ratio. At least 10 images from independent experiments were analyzed per genotype and condition. Student’s t test was used for statistical analysis.
RNA isolation and quantitative RT-PCR
To measure transcript levels, total RNA was extracted from whole larvae or dissected FBs of 30 animals using TRIZOL RNA Isolation Reagent (Invitrogen). First strand cDNA synthesis was performed using an oligo(dT)18 primer and RevertAid reverse transcriptase (ThermoFisher) under standard conditions. Quantitative PCR was performed on an aliquot of the cDNA with specific primers using the StepOnePlus Real-Time PCR System. Expression values were normalized to actin transcript levels. In all cases, three independent samples were collected from each condition and genotype, and duplicate measurements were taken. Student’s t test was used for statistical analysis. In the case of pre-miRNAs, first strand cDNA synthesis was performed using random hexamers. To quantify mature miRNA levels, we followed a two-step process [41]: (1) RT with a miRNA-specific stem loop primer (see S3 Table), followed by (2) quantitative PCR using both a miRNA-specific forward primer and an universal reverse primer [41] (see S3 Table).
Chromatin immunoprecipitation (ChIP) and qPCR
Immunoprecipitation assay was performed with specific anti-dMyc (P4C4-B10, DSHB) and anti-GFP (12A6, DSHB) antibodies on L3 control (w1118) larvae following the modENCODE protocol [42,43]. The specific immunoprecipitated DNA was detected by quantitative PCR using primers listed in S3 Table.
ChIP-seq data analysis
modENCODE ChIP-seq database (ENCSR191VCQ) from third instar larvae was analyzed to identify putative dMyc-regulated miRNA genes considering peaks located closer than 5kb to a TSS (Transcriptional Start Site) in replicated experiments and above optimal IDR (Irreproducibility Discovery Rate) threshold (https://epic.gs.washington.edu/modERN/). dMyc binding to the genomic region of 112 miRNA genes was also predicted through TransmiR ChIP-seq databases (ERX242709 and SRX160967; https://www.cuilab.cn/transmir). R (version 4.0.2) and Bioconductor (version 3.16) were used to define miRNAs’ genomic locations and to calculate distances to the nearest dMyc peak (TxDB: 10.18129/B9.bioc.TxDb.Dmelanogaster.UCSC.dm6.ensGene; [44]).
Bioinformatic analysis
The FIMO package from the MEME suite (https://meme-suite.org/meme/tools/fimo) was used to analyze the presence of E-box sequences on DNA regions overlapping with Myc peaks. The following Myc motifs obtained from JASPAR database [45] were used: (1) canonical E-box sequence (CACGTG) corresponding to human Myc (MA0147.3), human Myc:Max heterodimer (MA0059.1), and human MycN (MA0104.4); and (2) non-canonical E-box sequences (CACATG) corresponding to human Max binding site (MA0058.2). An unbiased de novo motif discovery using MEME (https://meme-suite.org/meme/tools/meme) was also performed. DNA sequences from the most significant Myc peaks from modENCODE datasets (signal enrichment above 95% corresponding to 800 peaks) were used as input. An enriched motif, named MEME2, was identified and used for the analysis (S2 Fig).
Quantification and statistical analysis
For starvation sensitivity assays statistics were performed using GraphPad Prism6, which uses the Kaplan-Meier estimator to calculate survival fractions as well as median and maximum survival values. Curves were compared using the log-rank (Mantel-Cox) test. The two-tailed p value indicates the value of the difference between the two entire survival distributions at comparison.
Graphpad Prism6 was used for statistical analysis and graphical representations based on three or more replicates for each experiment. All significance tests were carried out with unpaired two tailed Student’s t tests. Significance P values: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, nsp > 0.05.
Images were acquired on a Leica SP8 inverted confocal microscope and analyzed and processed using Fiji [46] and Adobe Photoshop. Tissue orientation and/or position was adjusted in the field of view for images presented. No relevant information was affected.
Supporting information
(A) qRT-PCR showing myc mRNA levels in control (w1118) and tub>dMyc larvae. (B) qRT-PCR showing pri-miR expression in control (w1118) and tub>dMyc larvae. Results are expressed as fold induction with respect to control animals. (C) qRT-PCR showing that actin mRNA levels remained unaffected in GSG162>mycRNAi larvae with either RU486 or vehicle treatment. The results are presented as CT (cycle threshold) values for each condition. Mean ± SEM. Unpaired two-tailed t-tests: * p<0.05; ** p<0.01; ***p<0.001; ns: not significant.
(TIF)
(A-D) Canonical (A-C) and non-canonical (D) Myc binding E-box sequences. (E) An enriched, putative Myc-binding motif identified by an unbiased de novo motif discovery using MEME (see Materials and methods for details).
(DOCX)
(A) Wing discs carrying the p53-sensor and expressing dcr-1RNAi under the control of the ptc-Gal4 driver (marked by the expression of RFP, in red) stained to visualize GFP (in green or white). (B) Wing discs expressing mycRNAi under the control of the ptc-Gal4 driver (marked by the expression of RFP, in red) and stained to visualize Dmp53 protein expression (in green or white). (C) Wing discs expressing mycRNAi under the control of the ci-Gal4 driver and stained to visualize dMyc protein expression (in red or white). (D-F) Wing discs carrying the indicated miR-sensors and stained to visualize GFP (in green or white). Red arrowheads depict the anterior-posterior (A-P) boundary. A: anterior; P: posterior.
(TIF)
(A) Fat body cells labeled to visualize p53Δ305-sensor (in green or white) from starved larvae expressing dMyc (marked by the expression of RFP, in red or white). Scale bars, 20 μm. (B) qRT-PCR showing dcr1 transcript levels in the FB of larvae from the indicated genotypes subjected to well fed (WF) or starved (STV) conditions. Results are expressed as fold induction with respect to control animals. Mean ± SEM. Unpaired two-tailed t-tests: ns: not significant.
(TIF)
(A-C) Survival rates to nutrient deprivation of adult flies of the indicated genotypes compared to control flies subjected to the same procedure. (A) The GSG132-Gal4 line was utilized to express dMyc or miR-305 specifically in the adult fat body. Newly eclosed adults of each genotype were transferred to food supplemented with 50 μg/ml of RU486 (Sigma). After 5 to 7 days, flies were transferred to vials containing 2% agar in PBS along with 50 μg/ml of RU486. (B) The Cg-Gal4, tub-Gal80ts line was used to express Dmp53 in the adult fat body. Newly eclosed adults of each genotype, grown at 18°C, were switched to 29°C. After 5 to 7 days at 29°C, flies were transferred to vials containing 2% agar in PBS. See S2 Table for n, p-value, median, and maximum survival values. Error bars represent SEM.
(TIF)
(XLSX)
(XLSX)
(XLSX)
Acknowledgments
We thank Marco Milan, Vienna Drosophila RNAi Center, Drosophila Bloomington Stock Center, and the Developmental Studies Hybridoma Bank for flies and antibodies.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Funding Statement
M.P.G., M.C.I and J.A.S are funded by PhD fellowships from CONICET. A.D. is a member of CONICET and Professor at UNL. This work was supported by the Agencia Nacional de Promoción Científica y Tecnológica, Argentina (PICT-2017-2036 and PICT-2019-01319 to A.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Eilers M, Eisenman RN. Myc’s broad reach. Genes Dev. 2008;22: 2755–2766. doi: 10.1101/gad.1712408 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dang C V., O’Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol. Academic Press; 2006;16: 253–264. doi: 10.1016/J.SEMCANCER.2006.07.014 [DOI] [PubMed] [Google Scholar]
- 3.Baluapuri A, Wolf E, Eilers M. Target gene-independent functions of MYC oncoproteins. Nat Rev Mol Cell Biol. Springer US; 2020;21: 255–267. doi: 10.1038/s41580-020-0215-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Blackwell TK, Huang,’ J, Ma A, Kretzner L, Alt FW, Eisenman,’ And RN, et al. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol. American Society for Microbiology; 1993;13: 5216–5224. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Deng K, Guo X, Wang H, Xia J. The lncRNA-MYC regulatory network in cancer. Tumor Biol. 2014;35: 9497–9503. doi: 10.1007/s13277-014-2511-y [DOI] [PubMed] [Google Scholar]
- 6.Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40: 43–50. doi: 10.1038/ng.2007.30 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.O’Donnell KA, Wentzel EA, Zeller KI, Dang C V., Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435: 839–843. doi: 10.1038/nature03677 [DOI] [PubMed] [Google Scholar]
- 8.He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature. NIH Public Access; 2005;435: 828. doi: 10.1038/nature03552 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. Springer US; 2019;20: 5–20. doi: 10.1038/s41580-018-0059-1 [DOI] [PubMed] [Google Scholar]
- 10.Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. Elsevier Inc.; 2012;148: 1172–87. doi: 10.1016/j.cell.2012.02.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136: 215–33. doi: 10.1016/j.cell.2009.01.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Eulalio A, Huntzinger E, Izaurralde E. GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay. Nat Struct Mol Biol. 2008;15: 346–53. doi: 10.1038/nsmb.1405 [DOI] [PubMed] [Google Scholar]
- 13.Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011;12: 99–110. doi: 10.1038/nrg2936 [DOI] [PubMed] [Google Scholar]
- 14.Wang X, Zhao X, Gao P, Wu M. c-Myc modulates microRNA processing via the transcriptional regulation of Drosha. Sci Rep. 2013;3: 1942. doi: 10.1038/srep01942 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bellosta P, Gallant P. Myc Function in Drosophila. Genes Cancer. 2010;1: 542–546. doi: 10.1177/1947601910377490 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Grewal SS, Li L, Orian A, Eisenman RN, Edgar B a. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol. 2005;7: 295–302. doi: 10.1038/ncb1223 [DOI] [PubMed] [Google Scholar]
- 17.Johnston L a, Prober D a, Edgar B a, Eisenman RN, Gallant P. Drosophila myc regulates cellular growth during development. Cell. 1999;98: 779–90. Available: http://www.ncbi.nlm.nih.gov/pubmed/10499795 doi: 10.1016/s0092-8674(00)81512-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Moreno E, Basler K. dMyc transforms cells into super-competitors. Cell. 2004;117: 117–129. Available: http://www.sciencedirect.com/science/article/pii/S0092867404002624 doi: 10.1016/s0092-8674(04)00262-4 [DOI] [PubMed] [Google Scholar]
- 19.Cova C de la, Abril M, Bellosta P. Drosophila Myc Regulates Organ Size by Inducing Cell Competition. Cell. 2004;117: 107–116. Available: http://www.sciencedirect.com/science/article/pii/S0092867404002144 doi: 10.1016/s0092-8674(04)00214-4 [DOI] [PubMed] [Google Scholar]
- 20.Gallant P. Myc function in drosophila. Cold Spring Harb Perspect Med. 2013;3. doi: 10.1101/cshperspect.a014324 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cordero JB, Stefanatos RK, Scopelliti A, Vidal M, Sansom OJ. Inducible progenitor-derived Wingless regulates adult midgut regeneration in Drosophila. EMBO J. Nature Publishing Group; 2012;31: 3901–17. doi: 10.1038/emboj.2012.248 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Li R, Zhou H, Jia C, Jin P, Ma F. Drosophila Myc Restores Immune Homeostasis of Imd Pathway via Activating MiR-277 to Inhibit imd/Tab2. PLoS Genet. 2020;16. doi: 10.1371/journal.pgen.1008989 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Daneshvar K, Nath S, Khan A, Shover W, Richardson C, Goodliffe JM. MicroRNA miR-308 regulates dMyc through a negative feedback loop in Drosophila. Biol Open. 2013;2: 1–9. doi: 10.1242/bio.20122725 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Nicholson L, Singh GK, Osterwalder T, Roman GW, Davis RL, Keshishian H. Spatial and Temporal Control of Gene Expression in Drosophila Using the Inducible GeneSwitch GAL4 System. I. Screen for Larval Nervous System Drivers. 2008; doi: 10.1534/genetics.107.081968 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kudron MM, Victorsen A, Gevirtzman L, Hillier LW, Fisher WW, Vafeados D, et al. The ModERN Resource: Genome-Wide Binding Profiles for Hundreds of Drosophila and Caenorhabditis elegans Transcription Factors. Genetics. 2018;208: 937–949. doi: 10.1534/genetics.117.300657 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Tong Z, Cui Q, Wang J, Zhou Y. TransmiR v2.0: an updated transcription factor-microRNA regulation database. Nucleic Acids Res. Oxford Academic; 2019;47: D253–D258. doi: 10.1093/NAR/GKY1023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Herter EK, Stauch M, Gallant M, Wolf E, Raabe T, Gallant P. snoRNAs are a novel class of biologically relevant Myc targets. BMC Biol.???; 2015;13: 25. doi: 10.1186/s12915-015-0132-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Barrio L, Dekanty A, Milán M. MicroRNA-Mediated Regulation of Dp53 in the Drosophila Fat Body Contributes to Metabolic Adaptation to Nutrient Deprivation. Cell Rep. 2014;8: 528–541. doi: 10.1016/j.celrep.2014.06.020 [DOI] [PubMed] [Google Scholar]
- 29.Herranz H, Pérez L, Martín F a, Milán M. A Wingless and Notch double-repression mechanism regulates G1-S transition in the Drosophila wing. EMBO J. 2008;27: 1633–45. doi: 10.1038/emboj.2008.84 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Herranz H, Hong X, Pérez L, Ferreira A, Olivieri D, Cohen SM, et al. The miRNA machinery targets Mei-P26 and regulates Myc protein levels in the Drosophila wing. EMBO J. 2010;29: 1688–98. doi: 10.1038/emboj.2010.69 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ferreira A, Boulan L, Perez L, Milán M. Mei-P26 mediates tissue-specific responses to the brat tumor suppressor and the dMyc Proto-Oncogene in Drosophila. Genetics. 2014;198: 249–258. doi: 10.1534/genetics.114.167502 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ingaramo MC, Sánchez JA, Perrimon N, Dekanty A. Fat Body p53 Regulates Systemic Insulin Signaling and Autophagy under Nutrient Stress via Drosophila Upd2 Repression. Cell Rep. 2020;33. doi: 10.1016/j.celrep.2020.108321 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sánchez JA, Ingaramo MC, Gervé MP, Thomas MG, Boccaccio GL, Dekanty A. FOXO-mediated repression of Dicer1 regulates metabolism, stress resistance, and longevity in Drosophila. Proc Natl Acad Sci U S A. Proc Natl Acad Sci U S A; 2023;120. doi: 10.1073/pnas.2216539120 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Bejarano F, Bortolamiol-Becet D, Dai Q, Sun K, Saj A, Chou Y-T, et al. A genome-wide transgenic resource for conditional expression of Drosophila microRNAs. Development. 2012;139: 2821–2831. doi: 10.1242/dev.079939 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Fulga TA, McNeill EM, Binari R, Yelick J, Blanche A, Booker M, et al. A transgenic resource for conditional competitive inhibition of conserved Drosophila microRNAs. Nat Commun 2015 61. Nature Publishing Group; 2015;6: 1–10. doi: 10.1038/ncomms8279 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Foronda D, Weng R, Verma P, Chen YW, Cohen SM. Coordination of insulin and notch pathway activities by microRNA miR-305 mediates adaptive homeostasis in the intestinal stem cells of the Drosophila gut. Genes Dev. 2014;28: 2421–2431. doi: 10.1101/gad.241588.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Ueda M, Sato T, Ohkawa Y, Inoue YH. Identification of miR-305, a microRNA that promotes aging, and its target mRNAs in Drosophila. Genes to Cells. 2018; doi: 10.1111/gtc.12555 [DOI] [PubMed] [Google Scholar]
- 38.Oliverio M, Schmidt E, Mauer J, Baitzel C, Hansmeier N, Khani S, et al. Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function. Nat Cell Biol. 2016;18: 328–336. doi: 10.1038/ncb3316 [DOI] [PubMed] [Google Scholar]
- 39.Brand a H, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118: 401–15. Available: http://www.ncbi.nlm.nih.gov/pubmed/8223268 doi: 10.1242/dev.118.2.401 [DOI] [PubMed] [Google Scholar]
- 40.Britton JS, Lockwood WK, Li L, Cohen SM, Edgar BA. Drosophila ‘ s Insulin / PI3-Kinase Pathway Coordinates Cellular Metabolism with Nutritional Conditions. 2002;2: 239–249. [DOI] [PubMed] [Google Scholar]
- 41.Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS, et al. Real-time PCR quantification of precursor and mature microRNA. Methods. Academic Press; 2008;44: 31–38. doi: 10.1016/j.ymeth.2007.09.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Landt S, Marinov G. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 2012; 1813–1831. doi: 10.1101/gr.136184.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sanchez JA, Mesquita D, Ingaramo MC, Ariel F, Milán M, Dekanty A. Eiger/TNFα-mediated Dilp8 and ROS production coordinate intra-organ growth in Drosophila. Perrimon N, editor. PLOS Genet. 2019;15: e1008133. doi: 10.1371/journal.pgen.1008133 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Lawrence M, Huber W, Pagès H, Aboyoun P, Carlson M, Gentleman R, et al. Software for computing and annotating genomic ranges. PLoS Comput Biol. PLoS Comput Biol; 2013;9. doi: 10.1371/journal.pcbi.1003118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Berhanu Lemma R, Turchi L, Blanc-Mathieu R, et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. Nucleic Acids Res; 2022;50: D165–D173. doi: 10.1093/nar/gkab1113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. Nature Publishing Group; 2012;9: 676–682. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]